Fig. 2: Number of somatic mutations shared, newly detected (N/D), and newly undetected (N/U) in the PDXs compared to the primary lymphoma samples according to WES analysis.
From: Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas
A stacked bar plot showing numbers of shared, N/D and N/U variants in all analyzed PDX models (VFN-D3, D6, D1, D4, D5, B3, M5R1, M1, T3, T6, T5, and T4) compared to the primary patient (P) samples.
